View in EDS PDF Full Text

Lenvatinib use across multiple cancer types: A single-centre evaluation of dosing patterns, tolerability and opportunities for dose optimisation.

Saved in:
Bibliographic Details
Title: Lenvatinib use across multiple cancer types: A single-centre evaluation of dosing patterns, tolerability and opportunities for dose optimisation.
Authors: Tan JQE; College of Medicine and Public Health, Flinders Health and Medical Research Institute, Flinders University, Adelaide, Australia.; SA Pharmacy, SA Health, Adelaide, South Australia, Australia.; Department of Medical Oncology, Flinders Medical Centre, Adelaide, Australia., Modi ND; College of Medicine and Public Health, Flinders Health and Medical Research Institute, Flinders University, Adelaide, Australia.; Clinical and Health Sciences, University of South Australia, Adelaide, Australia., Hassankhani R; Department of Medical Oncology, Flinders Medical Centre, Adelaide, Australia.; Department of Clinical Pharmacology, The Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Woodville South, Australia., Martin H; SA Pharmacy, SA Health, Adelaide, South Australia, Australia., Dyk MV; Department of Clinical Pharmacology, The Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Woodville South, Australia., Spencer S; Department of Clinical Pharmacology, The Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Woodville South, Australia., Sallustio BC; Department of Clinical Pharmacology, The Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Woodville South, Australia.; Discipline of Pharmacology, School of Biomedicine, The University of Adelaide, Adelaide, Australia., Kichenadasse G; College of Medicine and Public Health, Flinders Health and Medical Research Institute, Flinders University, Adelaide, Australia.; Department of Medical Oncology, Flinders Medical Centre, Adelaide, Australia.
Source: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2026 Jun 11, pp. 10781552261459659. Date of Electronic Publication: 2026 Jun 11.
Publication Type: Journal Article
Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 9511372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-092X (Electronic) Linking ISSN: 10781552 NLM ISO Abbreviation: J Oncol Pharm Pract Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42272400
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Lenvatinib use across multiple cancer types: A single-centre evaluation of dosing patterns, tolerability and opportunities for dose optimisation.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Tan+JQE%22">Tan JQE</searchLink>; College of Medicine and Public Health, Flinders Health and Medical Research Institute, Flinders University, Adelaide, Australia.; SA Pharmacy, SA Health, Adelaide, South Australia, Australia.; Department of Medical Oncology, Flinders Medical Centre, Adelaide, Australia.<br /><searchLink fieldCode="AU" term="%22Modi+ND%22">Modi ND</searchLink>; College of Medicine and Public Health, Flinders Health and Medical Research Institute, Flinders University, Adelaide, Australia.; Clinical and Health Sciences, University of South Australia, Adelaide, Australia.<br /><searchLink fieldCode="AU" term="%22Hassankhani+R%22">Hassankhani R</searchLink>; Department of Medical Oncology, Flinders Medical Centre, Adelaide, Australia.; Department of Clinical Pharmacology, The Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Woodville South, Australia.<br /><searchLink fieldCode="AU" term="%22Martin+H%22">Martin H</searchLink>; SA Pharmacy, SA Health, Adelaide, South Australia, Australia.<br /><searchLink fieldCode="AU" term="%22Dyk+MV%22">Dyk MV</searchLink>; Department of Clinical Pharmacology, The Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Woodville South, Australia.<br /><searchLink fieldCode="AU" term="%22Spencer+S%22">Spencer S</searchLink>; Department of Clinical Pharmacology, The Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Woodville South, Australia.<br /><searchLink fieldCode="AU" term="%22Sallustio+BC%22">Sallustio BC</searchLink>; Department of Clinical Pharmacology, The Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Woodville South, Australia.; Discipline of Pharmacology, School of Biomedicine, The University of Adelaide, Adelaide, Australia.<br /><searchLink fieldCode="AU" term="%22Kichenadasse+G%22">Kichenadasse G</searchLink>; College of Medicine and Public Health, Flinders Health and Medical Research Institute, Flinders University, Adelaide, Australia.; Department of Medical Oncology, Flinders Medical Centre, Adelaide, Australia.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229511372%22">Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners</searchLink> [J Oncol Pharm Pract] 2026 Jun 11, pp. 10781552261459659. <i>Date of Electronic Publication: </i>2026 Jun 11.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22SAGE+Publications%22">SAGE Publications </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9511372 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1477-092X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210781552%22">10781552 </searchLink><i>NLM ISO Abbreviation: </i>J Oncol Pharm Pract <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42272400
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1177/10781552261459659
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 10781552261459659
    Titles:
      – TitleFull: Lenvatinib use across multiple cancer types: A single-centre evaluation of dosing patterns, tolerability and opportunities for dose optimisation.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Tan JQE
      – PersonEntity:
          Name:
            NameFull: Modi ND
      – PersonEntity:
          Name:
            NameFull: Hassankhani R
      – PersonEntity:
          Name:
            NameFull: Martin H
      – PersonEntity:
          Name:
            NameFull: Dyk MV
      – PersonEntity:
          Name:
            NameFull: Spencer S
      – PersonEntity:
          Name:
            NameFull: Sallustio BC
      – PersonEntity:
          Name:
            NameFull: Kichenadasse G
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 11
              M: 06
              Text: 2026 Jun 11
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1477-092X
          Titles:
            – TitleFull: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
              Type: main
ResultId 1